Myszkowski Kenneth Allen
- SEC CIK
- 0001486672
No open-market purchases or sales filed in the past year.
Current role at each company
- ARWR Arrowhead Pharmaceuticals, Inc.Chief Financial Officeras of Jan 7, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Myszkowski Kenneth Allen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 (view filing) | Jan 6-7 | 1 day | Myszkowski Kenneth AllenChief Financial Officer | SSale | −45.2K | $19.77 | −$893.1K | −9.0%455.4K after | 4 lots10b5-1 |
| Mar 8, 2024 (view filing) | Mar 6 | 2 days | Myszkowski Kenneth AllenChief Financial Officer | SSale | −40.0K | $35.19 | −$1.41M | −9.1%400.6K after | |
| Jan 8, 2024 (view filing) | Jan 5 | 3 days | Myszkowski Kenneth AllenChief Financial Officer | SSale | −16.1K | $35.27 | −$567.9K | −3.5%440.6K after | 3 lots10b5-1 |
| Jun 29, 2023 (view filing) | Jun 27 | 2 days | Myszkowski Kenneth AllenChief Financial Officer | SSale | −15.0K | $36.20 | −$543.0K | −3.8%381.7K after | |
| Dec 30, 2022 (view filing) | Dec 29 | 1 day | Myszkowski Kenneth AllenChief Financial Officer | SSale | −30.6K | $40.00 | −$1.23M | −8.3%336.7K after | |
| Jan 6, 2022 (view filing) | Jan 5 | 1 day | Myszkowski Kenneth AllenChief Financial Officer | SSale | −40.0K | $61.70 | −$2.47M | −7.9%464.0K after | 4 lots |